Physician Attitudes toward New Biomedical HIV Prevention Interventions in Youth

医生对青年新的生物医学艾滋病毒预防干预措施的态度

• 批准号: 8899620
• 负责人: Tanya L. Kowalczyk Mullins
• 金额: $ 13.01万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-19 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8899620
• 关键词: 21 year old; Acquired Immunodeficiency Syndrome; Address; Adolescent; Adolescent Medicine; Adolescent Medicine Trials Network; Adolescent and Young Adult; Adopted; Adult; Advisory Committees; Affect; Anti-Retroviral Agents; Area; Attitude; Automobile Driving; Basic Science; Behavior; Behavioral; Caring; Childhood; Clinical; Clinical Investigator; Clinical Research; Committee Members; Complement; Counseling; Data; Data Collection; Development; Development Plans; Diffusion of Innovation; Effectiveness; Environment; Epidemiology; Ethics; Faculty; Funding; Future; Goals; Grant; HIV; Health; Healthy People 2020; Human immunodeficiency virus test; Incidence; Individual; Infection; Infection prevention; Intention; International; Intervention; Intervention Studies; Interview; Journals; K-Series Research Career Programs; Knowledge; Light; Local Microbicides; Manuscripts; Master of Science; Medical; Medical center; Mentors; Mentorship; Methods; New Agents; Oral; Outcome; Pediatric Hospitals; Pharmaceutical Preparations; Phase; Physician' s Role; Physicians; Planning Theory; Play; Policies; Preparation; Prevention; Prevention Measures; Prevention strategy; Preventive; Preventive Intervention; Primary Care Physician; Primary Health Care; Primary Prevention; Prophylactic treatment; Public Health; Publishing; Qualitative Methods; Recommendation; Research; Research Infrastructure; Research Methodology; Research Personnel; Research Training; Resource Development; Role; Sampling; Sexual Health; Sexually Transmitted Diseases; Structure; Survey Methodology; Surveys; Testing; Training; United States; United States National Institutes of Health; Validation; Virus Diseases; Work; Youth; age group; base; career; career development; design; experience; health disparity; improved; medical specialties; meetings; member; microbicide; novel; pediatrician; prevent; prevention service; programs; reproductive health of adolescents; skills; theories; therapy design; uptake; vaginal microbicide

DESCRIPTION (provided by applicant): Between 2006 and 2009, the incidence of human immunodeficiency virus (HIV) infections increased significantly among adolescents and young adults. Although new biomedical primary prevention agents such as microbicides and pre-exposure prophylaxis (PrEP) decrease rates of HIV acquisition in trials, their effective-ness in practice will depend largely on clinician recommendations. However, despite the recent FDA approval of the first oral PrEP agent, data are not available regarding physician knowledge and attitudes about these methods with regard to use in youth. Physician intention to recommend these agents to adolescents, which is likely to be a powerful predictor of actual recommendations, is also unknown. This lack of data is a significant problem because the information will be critical to the design of interventions to improve the rate at which physicians recommend these agents to adolescents, an age group disproportionately affected by HIV infection. Dr. Mullins's long-term goal is to decrease HIV acquisition among adolescents through an independent research career focusing on the successful dissemination and uptake of new biomedical prevention agents. The candidate has demonstrated strong potential to conduct research. She has been the first-author for 5 pri- mary research manuscripts published in high-impact pediatric journals and presented her findings at national and international research meetings. She developed basic research skills through coursework culminating in a Master of Science in Epidemiology/Clinical Research. The overall objective of this K23 application, which is the next step toward attainment of the candidate's long-term goal, is to define the factors that influence physician intention to recommend microbicides and PrEP to adolescents. The central hypothesis is that physicians will have low intention to recommend microbicides and PrEP to adolescents, and factors such as knowledge, cur- rent HIV prevention practices, attitudes, subjective norm, and structural/policy factors will influence these inten- tions. The rationale underlying the proposed research is that, once the factors that influence intention to rec- ommend new agents are understood, such information can be used to design interventions that accelerate recommendations for new HIV prevention agents among clinicians who care for adolescents, which in turn will decrease adolescent HIV acquisition. The proposed research involves primary data collection using a mixed methods approach to explore and quantify physician attitudes toward and intentions to recommend new bio- medical HIV prevention agents to youth and to identify factors associated with these intentions. In the first phase, individual interviews will be conducted with 40 physicians who provide primary care to adolescents in order to explore and define the salient attitudes. The findings from this phase will inform the development of a new, validated survey designed to quantify physician attitudes and intentions with regard to recommending and prescribing microbicides and PrEP to adolescents for HIV prevention. In the final phase, the new survey will be administered to a national sample of 2500 physicians who provide primary care to adolescents to assess inten- tions to recommend and prescribe microbicides and PrEP and define predictors of these intentions. The pro- posed research will contribute novel information regarding the factors that influence physician intention to rec- ommend new prevention agents. The results will inform tailored interventions to educate physicians about these agents in order to maximize adolescent HIV prevention efforts and also will be applicable in the devel- opment of interventions to improve dissemination of other HIV prevention measures in development. In order to achieve her long-term career goal and the objectives of this application, the candidate will require training in mixed methods research (including qualitative and survey methods), health disparities, eth- ics of sexual health research, use of antiretroviral medications, and design/implementation of intervention stud- ies. These needs will be met through a combination of strong mentorship, didactics, and clinical experience. The mentorship team includes researchers with expertise in relevant content areas and mentoring junior facul- ty. Dr. Jessica Kahn, the primary mentor, provides expertise in prevention of sexually transmitted infections in adolescents and methodologic expertise in (1) the assessment of physician intentions to recommend STI pre- vention agents and (2) qualitative and survey research methods. She holds current R01 funding and is an ac- tive investigator and leader in the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Dr. Kahn has successfully mentored many trainees and junior faculty. Her expertise will be complemented by that of the co-mentors and advisory committee members. The scientific environment at Cincinnati Children's Hospital Medical Center (CCHMC) provides an ideal setting for Dr. Mullins to achieve research independence. CCHMC has supported numerous junior investiga- tors, and 36 faculty hold NIH career development awards. The Division of Adolescent Medicine, which has seven NIH-funded faculty members and a focus on adolescent reproductive health research, had $1.7 million in grant support in 2011. The Division provides infrastructure and a wealth of intellectual resources for the de- velopment of the candidate. In summary, the candidate's demonstrated potential for research, novel research plan, relevant career development plan, excellent mentorship team, and outstanding research environment contribute to her ability to achieve research independence with the essential support provided by a K23 career development award.

描述（由申请人提供）：2006年至2009年间，青少年和年轻人中人类免疫缺陷病毒（HIV）感染的发病率显著增加。虽然新的生物医学一级预防药物，如杀微生物剂和暴露前预防（PrEP）在试验中降低了艾滋病毒感染率，但它们在实践中的有效性将在很大程度上取决于临床医生的建议。然而，尽管最近FDA批准了第一种口服PrEP药物，但关于医生在青少年中使用这些方法的知识和态度的数据还没有。医生向青少年推荐这些药物的意图，可能是实际建议的有力预测因素，也是未知的。数据的缺乏是一个重大问题，因为这些信息对于设计干预措施以提高医生的死亡率至关重要